|
GANC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64823710235851E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7430501486615E-14 |
| Normal-vs-Stage2 |
6.704100E-03 |
| Normal-vs-Stage3 |
2.05999999999262E-05 |
| Normal-vs-Stage4 |
3.12319999995481E-06 |
| Stage1-vs-Stage2 |
1.098370E-01 |
| Stage1-vs-Stage3 |
8.302200E-03 |
| Stage1-vs-Stage4 |
9.125600E-01 |
| Stage2-vs-Stage3 |
9.493600E-01 |
| Stage2-vs-Stage4 |
1.611990E-01 |
| Stage3-vs-Stage4 |
5.132300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.38475905689484E-13 |
| Normal-vs-AfricanAmerican |
2.002800E-03 |
| Normal-vs-Asian |
4.18300000000205E-05 |
| Caucasian-vs-AfricanAmerican |
9.034400E-01 |
| Caucasian-vs-Asian |
3.602400E-01 |
| AfricanAmerican-vs-Asian |
5.220800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.05950043077985E-10 |
| Normal-vs-Female |
2.90156787485785E-12 |
| Male-vs-Female |
1.658640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.07811545749337E-12 |
| Normal-vs-Age(41-60Yrs) |
8.78999995013174E-09 |
| Normal-vs-Age(61-80Yrs) |
6.29489999999233E-05 |
| Normal-vs-Age(81-100Yrs) |
1.012440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.367800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.106200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.986200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.221200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.353000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.055600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.974300E-04 |
| Classical-VS-Follicular |
2.932600E-01 |
| Classical-VS-Other |
5.991800E-01 |
| Classical-VS-Normal |
4.44089209850063E-16 |
| Tall-VS-Follicular |
1.083780E-01 |
| Tall-VS-Other |
2.761400E-01 |
| Tall-VS-Normal |
2.483800E-02 |
| Follicular-VS-Other |
9.236600E-01 |
| Follicular-VS-Normal |
2.429700E-04 |
| Other-VS-Normal |
2.521100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.78780001703194E-09 |
| Normal-vs-N1 |
1.56577000000047E-05 |
| N0-vs-N1 |
1.903640E-01 |
|
|
